These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12380880)

  • 21. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
    Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of delayed or incomplete diphtheria-tetanus-pertussis vaccination in parallel urban and rural birth cohorts of 30,956 infants in Tanzania.
    Nadella P; Smith ER; Muhihi A; Noor RA; Masanja H; Fawzi WW; Sudfeld CR
    BMC Infect Dis; 2019 Feb; 19(1):188. PubMed ID: 30808282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
    BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.
    Frampton JE; Keating GM
    BioDrugs; 2006; 20(6):371-89. PubMed ID: 17176125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity against tetanus and effect of vaccination in Turkey.
    Coplu N; Esen B; Gozalan A; Kurtoglu D; Ishid S; Miyamura K
    Scand J Infect Dis; 2006; 38(11-12):1009-16. PubMed ID: 17148069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine.
    Ramsay ME; Rao M; Begg NT; Redhead K; Attwell AM
    Lancet; 1993 Jul; 342(8865):203-5. PubMed ID: 8100929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults.
    Hoel T; Wolter JM; Schuerman LM
    Eur J Emerg Med; 2006 Apr; 13(2):67-71. PubMed ID: 16525231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Liang JL; Tiwari T; Moro P; Messonnier NE; Reingold A; Sawyer M; Clark TA
    MMWR Recomm Rep; 2018 Apr; 67(2):1-44. PubMed ID: 29702631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccination against diphtheria and tetanus of children with allergic diseases and upset schedule of DPT vaccine administration].
    Kostinov MP; Balabolkin II; Maksimova NM; Egor'kov NA; Gervazieva VB
    Pediatriia; 1991; (2):68-71. PubMed ID: 1676151
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses.
    Marchand-Janssen C; Loulergue P; Mouthon L; Mahr A; Blanche P; Deforges L; Lebon P; Cohen P; Pagnoux C; Le Guern V; Bienvenu B; Aouba A; Guillevin L; Launay O
    Rheumatology (Oxford); 2011 Jun; 50(6):1099-105. PubMed ID: 21258052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children.
    Diez-Domingo J; Delgado JD; Ballester A; Baldó JM; Planelles MV; Garcés M; Graullera M; Ubeda MI; Sánchez F; Sánchez MM; Azor E; Cabrera A; López F; Alvarez M; San-Martín M; González A; Boisnard F; Thomas S
    Pediatr Infect Dis J; 2005 Mar; 24(3):219-24. PubMed ID: 15750457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immunization against tetanus during pregnancy for protective antibody titres and specific antibody responses of infants.
    Kütükçüler N; Kurugöl Z; Egemen A; Yenigün A; Vardar F
    J Trop Pediatr; 1996 Oct; 42(5):308-9. PubMed ID: 8936966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine.
    Stewart TA; Nolan TM; Hogg G; McEwen J
    J Paediatr Child Health; 1996 Oct; 32(5):378-81. PubMed ID: 8933394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.
    Swartz TA; Saliou P; Catznelson E; Blondeau C; Gil I; Peled T; Havkin O; Fletcher M
    Eur J Epidemiol; 2003; 18(8):827-33. PubMed ID: 12974560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.